These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2302711

  • 21. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.
    Cancer Res; 1999 Jul 15; 59(14):3365-8. PubMed ID: 10416595
    [Abstract] [Full Text] [Related]

  • 22. Increased N-myc expression following progressive growth of human neuroblastoma.
    Rosen N, Reynolds CP, Thiele CJ, Biedler JL, Israel MA.
    Cancer Res; 1986 Aug 15; 46(8):4139-42. PubMed ID: 3731081
    [Abstract] [Full Text] [Related]

  • 23. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 24. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD.
    Cancer Res; 1994 Oct 01; 54(19):5036-40. PubMed ID: 7923112
    [Abstract] [Full Text] [Related]

  • 25. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM.
    Oncogene; 1990 Dec 01; 5(12):1821-7. PubMed ID: 2284101
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
    Tonin PN, Yeger H, Stallings RL, Srinivasan PR, Lewis WH.
    Oncogene; 1989 Sep 01; 4(9):1117-21. PubMed ID: 2780050
    [Abstract] [Full Text] [Related]

  • 28. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R.
    Nat Genet; 1993 Jun 01; 4(2):187-90. PubMed ID: 8102298
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
    Tonini GP, Verdona G, Garaventa A, Cornaglia-Ferraris P.
    Anticancer Res; 1987 Jun 01; 7(4B):729-32. PubMed ID: 3314672
    [Abstract] [Full Text] [Related]

  • 31. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 32. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
    Hiemstra JL, Schneider SS, Brodeur GM.
    Prog Clin Biol Res; 1994 Apr 15; 385():51-7. PubMed ID: 7972237
    [Abstract] [Full Text] [Related]

  • 33. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

  • 34. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.
    Prog Clin Biol Res; 1994 Mar 27; 385():43-9. PubMed ID: 7972236
    [Abstract] [Full Text] [Related]

  • 35. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
    Flickinger KS, Judware R, Lechner R, Carter WG, Culp LA.
    Exp Cell Res; 1994 Jul 27; 213(1):156-63. PubMed ID: 8020586
    [Abstract] [Full Text] [Related]

  • 36. Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage.
    Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM.
    Prog Clin Biol Res; 1985 Jul 27; 175():105-13. PubMed ID: 3991726
    [No Abstract] [Full Text] [Related]

  • 37. Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
    Corrias MV, Cornaglia-Ferraris P, Di Martino D, Stenger AM, Lanino E, Boni L, Tonini GP.
    Anticancer Res; 1990 Jul 27; 10(4):897-902. PubMed ID: 1974410
    [Abstract] [Full Text] [Related]

  • 38. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification.
    Tanaka T, Seeger RC, Tanabe M, Hiyama E, Shimoda H, Ida N.
    Cancer Detect Prev; 1994 Jul 27; 18(4):283-9. PubMed ID: 7982238
    [Abstract] [Full Text] [Related]

  • 39. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K, Bergh J, Nilsson K.
    J Cell Biochem; 1986 Jul 27; 31(4):297-304. PubMed ID: 3020069
    [Abstract] [Full Text] [Related]

  • 40. Amplification of N-myc oncogene in human melanoma cells.
    Bauer J, Sokol L, Stríbrná J, Kremen M, Krajsová I, Hausner P, Hejnar P.
    Neoplasma; 1990 Jul 27; 37(3):233-8. PubMed ID: 2370914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.